JP2022531177A5 - - Google Patents
Info
- Publication number
- JP2022531177A5 JP2022531177A5 JP2021564246A JP2021564246A JP2022531177A5 JP 2022531177 A5 JP2022531177 A5 JP 2022531177A5 JP 2021564246 A JP2021564246 A JP 2021564246A JP 2021564246 A JP2021564246 A JP 2021564246A JP 2022531177 A5 JP2022531177 A5 JP 2022531177A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- derivative
- disease
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962840235P | 2019-04-29 | 2019-04-29 | |
| US62/840,235 | 2019-04-29 | ||
| PCT/US2020/030409 WO2020223310A2 (en) | 2019-04-29 | 2020-04-29 | Methods for treating neurodegenerative disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022531177A JP2022531177A (ja) | 2022-07-06 |
| JP2022531177A5 true JP2022531177A5 (https=) | 2023-05-10 |
Family
ID=73029186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564246A Pending JP2022531177A (ja) | 2019-04-29 | 2020-04-29 | 神経変性障害を治療するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220226357A1 (https=) |
| EP (1) | EP3962492A4 (https=) |
| JP (1) | JP2022531177A (https=) |
| CN (1) | CN114761021A (https=) |
| WO (1) | WO2020223310A2 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007018275A1 (ja) * | 2005-08-11 | 2009-02-19 | 独立行政法人産業技術総合研究所 | ローリングモデルに基づく、送達媒体の設計 |
| JP5465542B2 (ja) * | 2008-02-22 | 2014-04-09 | 片山化学工業株式会社 | 合成糖脂質含有リポソーム |
| EP2473174A4 (en) * | 2009-09-01 | 2014-02-26 | Lz Therapeutics Inc | TRANSMUCOSAL GANGLIOSIDE FORMULATIONS |
| KR101880411B1 (ko) * | 2009-10-19 | 2018-07-19 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 중추신경계의 퇴행성 질환을 예방 및/또는 치료하는 신규 조성물 |
| CA2840224C (en) * | 2011-06-22 | 2019-08-13 | The General Hospital Corporation | Treatment of proteinopathies |
| US20140187507A1 (en) * | 2012-12-14 | 2014-07-03 | Rutgers, The State University Of New Jersey | Treatment of parkinsons disease with glycolipids |
| CA2944402A1 (en) * | 2014-04-08 | 2015-10-15 | Prothena Biosciences Limited | Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein |
| GB201512203D0 (en) * | 2015-07-13 | 2015-08-19 | Lundbeck & Co As H | Agents,uses and methods |
| WO2017015491A1 (en) * | 2015-07-21 | 2017-01-26 | Thomas Jefferson University | Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathways |
-
2020
- 2020-04-29 JP JP2021564246A patent/JP2022531177A/ja active Pending
- 2020-04-29 CN CN202080044151.0A patent/CN114761021A/zh active Pending
- 2020-04-29 EP EP20798336.2A patent/EP3962492A4/en active Pending
- 2020-04-29 WO PCT/US2020/030409 patent/WO2020223310A2/en not_active Ceased
- 2020-04-29 US US17/607,294 patent/US20220226357A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023528039A (ja) | 改変環状ポリヌクレオチド | |
| AU783448B2 (en) | Induced regeneration and repair of damaged neurons and nerve axon myelin | |
| JP2022501040A5 (https=) | ||
| WO2008003511A1 (en) | Use of aminothiazole derivative compounds, pharmaceutical compositions thereof, in the treatment of diseases characterized by abnormal repression of gene transcription, particularly huntington's disease | |
| US9809823B2 (en) | DNA aptamers for promoting remyelination | |
| JP2022513454A (ja) | ＡＩＭＰ２－ＤＸ２およびｍｉＲ－１４２の標的核酸を含むベクター、ならびにその使用 | |
| JP2024517710A5 (https=) | ||
| JP2024540537A5 (https=) | ||
| JP2020105169A5 (https=) | ||
| JP2021534206A5 (https=) | ||
| JP2022531177A5 (https=) | ||
| WO2003084542A1 (en) | Neurotrophic factor production accelerator | |
| CN114225035A (zh) | 环状RNA Cwc27下调剂在制备预防和/或治疗阿尔茨海默病的药物中的应用 | |
| JP2021518392A5 (https=) | ||
| US20240182921A1 (en) | Compositions and methods for the treatment of hemophilia | |
| JP2023509067A (ja) | コドン最適化ＴＩＦ１γポリヌクレオチドを含む組換えベクターおよびその用途 | |
| JP2023536067A5 (https=) | ||
| US20220323440A1 (en) | Compositions and methods for treating spinal cord injury and synaptic dysfunction | |
| JP2022549116A (ja) | タウタンパク質の蓄積、凝集及びタングル形成抑制用組成物及びその抑制方法 | |
| JP2022525136A5 (https=) | ||
| CN116568804A (zh) | 工程化环状多核苷酸 | |
| US20260115318A1 (en) | Gene correction induced neural stem cells using huntingtin gene-specific guide rna, and cell therapeutic agent using the same | |
| CN111617255A (zh) | 用于治疗中枢神经系统紊乱的组合疗法 | |
| KR20250047689A (ko) | 알파-시누클레인 응집 억제용 조성물 및 응집억제 방법 | |
| US20110262387A1 (en) | Methods and materials for reducing or suppressing amyloid deposition |